Conference
A phase I study of R04929097, an oral gamma secretase inhibitor, in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575).
Abstract
3082
Authors
Richter S; McWhirter E; Chen EX; Tran B; Hotte SJ; Stathis A; Hirte HW; Razak ARA; Laughlin A; Wang L
Volume
30
Pagination
pp. 3082-3082
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2012
DOI
10.1200/jco.2012.30.15_suppl.3082
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X